Who knows which one in our generous pipeline will get us heading way NORTH. As Dr. Rubinfeld said (with AMGEN) the one that finally sent them higher was a surprise, maybe number 5 on the list. But it was the spark that ignited that small biotech startup, and they struggled all along the way.

Nobody here knows when we will leave the launch pad, but I'm sure thankful we have a fat pipeline and some very experienced staff who have been down this road before.

The science and the connections Ambs has are strong. The waiting is the hardest part for us shareholders ****

Aloha, bsr